Ramelteon and Doxepin Interaction

Drug interaction information between Ramelteon and Doxepin.

Ramelteon and Doxepin have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Ramelteon and Doxepin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Ramelteon

Melatonin Receptor Agonist

Drug B

Doxepin

Tricyclic Antidepressant (TCA)

How They Interact

Taking doxepin can raise the levels of ramelteon in your body by slowing down its breakdown.

FDA Label Information

( 7.1 ) Doxepin: Increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with doxepin. Doxepin The AUC 0-inf and C max of ramelteon increased by approximately 66% and 69%, respectively, upon coadministration of doxepin with ramelteon. Patients should be closely monitored when ramelteon is coadministered with doxepin [see Clinical Pharmacology (12.5) ] .

Doxepin Also Interacts With

View all Doxepin interactions →

Frequently Asked Questions

What SPL severity band is on file for Ramelteon + Doxepin?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Ramelteon has 7 labeled pairs on file vs Doxepin's 3. In the minor band specifically: Ramelteon has 5 (also Donepezil, Rifampin, Fluvoxamine, Itraconazole); Doxepin has 3 (also Cimetidine, Dopamine).

What mechanism field is on file for Ramelteon and Doxepin?

Taking doxepin can raise the levels of ramelteon in your body by slowing down its breakdown.

Ramelteon's labeled portfolio outnumbers Doxepin

SPL source-record counts only. This page's band is minor · classes on file: Ramelteon (Melatonin Receptor Agonist); Doxepin (Tricyclic Antidepressant (TCA)).

Ramelteon

0 major · 2 moderate · 5 minor · 7 total

Doxepin

0 major · 0 moderate · 3 minor · 3 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.